Its exact mechanism of action has not yet been completely elucidated, but a reasonable explanation for interconnecting hemostatic components and cancer biology is the production of the prime physiological initiator of coagulation, Tissue factor (TF) by tumor (Khorana et al., 2007; Ruf et al., 2016). The gene discussed is TF; the disease is cancer.